标题
Lung Microbiome in Cystic Fibrosis
作者
关键词
-
出版物
Life-Basel
Volume 11, Issue 2, Pages 94
出版商
MDPI AG
发表日期
2021-01-28
DOI
10.3390/life11020094
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Role of Lung and Gut Microbiota in the Pathology of Asthma
- (2020) Weronika Barcik et al. IMMUNITY
- The Cross-Talk Between Gut Microbiota and Lungs in Common Lung Diseases
- (2020) Dapeng Zhang et al. Frontiers in Microbiology
- TAS2R38 is a novel modifier gene in patients with cystic fibrosis
- (2020) Alice Castaldo et al. Scientific Reports
- The Microbiome in Cystic Fibrosis Pulmonary Disease
- (2020) Alice Françoise et al. Genes
- Maintenance tobramycin primarily affects untargeted bacteria in the CF sputum microbiome
- (2020) Maria T Nelson et al. THORAX
- High-Resolution Longitudinal Dynamics of the Cystic Fibrosis Sputum Microbiome and Metabolome through Antibiotic Therapy
- (2020) Ruma Raghuvanshi et al. mSystems
- Pulmonary exacerbations in adults with cystic fibrosis - a grown-up issue in a changing CF landscape
- (2020) Gemma E. Stanford et al. CHEST
- Cystic fibrosis: Physiopathology and the latest pharmacological treatments
- (2020) Carla Fonseca et al. PHARMACOLOGICAL RESEARCH
- Two CFTR mutations within codon 970 differently impact on the chloride channel functionality
- (2019) Felice Amato et al. HUMAN MUTATION
- Pseudomonas aeruginosa eradication therapy and risk of acquiring Aspergillus in young children with cystic fibrosis
- (2019) Sabariah Noor Harun et al. THORAX
- Challenges in understanding lung microbiome: It is NOT like the gut microbiome
- (2019) De Chang et al. RESPIROLOGY
- Modulation of Pulmonary Microbiota by Antibiotic or Probiotic Aerosol Therapy: A Strategy to Promote Immunosurveillance against Lung Metastases
- (2018) Valentino Le Noci et al. Cell Reports
- Diet, Microbiota and Gut-Lung Connection
- (2018) Swadha Anand et al. Frontiers in Microbiology
- Paradigms of Lung Microbiota Functions in Health and Disease, Particularly, in Asthma
- (2018) Elliot Mathieu et al. Frontiers in Physiology
- Ivacaftor, a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator, Enhances Ciprofloxacin Activity Against Pseudomonas aeruginosa
- (2018) Do-Yeon Cho et al. American Journal of Rhinology & Allergy
- Clinical expression of cystic fibrosis in a large cohort of Italian siblings
- (2018) Vito Terlizzi et al. BMC Pulmonary Medicine
- Raw BIA variables are predictors of muscle strength in patients with chronic obstructive pulmonary disease
- (2017) F de Blasio et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Concordance between upper and lower airway microbiota in infants with cystic fibrosis
- (2017) Sabine M.P.J. Prevaes et al. EUROPEAN RESPIRATORY JOURNAL
- Airway microbiota across age and disease spectrum in cystic fibrosis
- (2017) Edith T. Zemanick et al. EUROPEAN RESPIRATORY JOURNAL
- Activity of innate antimicrobial peptides and ivacaftor against clinical cystic fibrosis respiratory pathogens
- (2017) Joanna E. Payne et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Short Palate, Lung, and Nasal Epithelial Clone 1 Has Antimicrobial and Antibiofilm Activities against the Burkholderia cepacia Complex
- (2016) Saira Ahmad et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Recent Advances on Nitric Oxide in the Upper Airways
- (2016) Mauro Maniscalco et al. CURRENT MEDICINAL CHEMISTRY
- Analysis of Lung Microbiota in Bronchoalveolar Lavage, Protected Brush and Sputum Samples from Subjects with Mild-To-Moderate Cystic Fibrosis Lung Disease
- (2016) Deborah A. Hogan et al. PLoS One
- The maternal microbiota drives early postnatal innate immune development
- (2016) M. Gomez de Aguero et al. SCIENCE
- Evaluation of body composition in COPD patients using multifrequency bioelectrical impedance analysis
- (2016) Francesca de Blasio et al. International Journal of Chronic Obstructive Pulmonary Disease
- Data Mining of Lung Microbiota in Cystic Fibrosis Patients
- (2016) Jianguo Li et al. PLoS One
- Lung microbiota across age and disease stage in cystic fibrosis
- (2015) Bryan Coburn et al. Scientific Reports
- Pseudomonas aeruginosa in Cystic Fibrosis Patients With G551D-CFTR Treated With Ivacaftor
- (2014) Sonya L. Heltshe et al. CLINICAL INFECTIOUS DISEASES
- Antibacterial properties of the CFTR potentiator ivacaftor
- (2014) Leah R. Reznikov et al. Journal of Cystic Fibrosis
- Lung microbiota promotes tolerance to allergens in neonates via PD-L1
- (2014) Eva S Gollwitzer et al. NATURE MEDICINE
- Unique microbial communities persist in individual cystic fibrosis patients throughout a clinical exacerbation
- (2013) Katherine E Price et al. Microbiome
- The Adult Cystic Fibrosis Airway Microbiota Is Stable over Time and Infection Type, and Highly Resilient to Antibiotic Treatment of Exacerbations
- (2012) Anthony A. Fodor et al. PLoS One
- Decade-long bacterial community dynamics in cystic fibrosis airways
- (2012) J. Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa
- (2010) Vanja Klepac-Ceraj et al. ENVIRONMENTAL MICROBIOLOGY
- Cystic Fibrosis Pulmonary Guidelines
- (2009) Patrick A. Flume et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search